Synthpop hits $23M in funding

CAMBRIDGE, Mass. – Synthpop, Inc., a health care AI company building agentic automation to eliminate administrative bottlenecks in payer, provider and patient operations, has received a $15 million Series A, bringing the company’s total funding to $23 million. 

Over the past year, Synthpop says it has demonstrated significant traction, processing over 2 million patients and now integrating with eight major EHR systems. 

"Point solutions can't fix operational bottlenecks," said Elad Ferber, CEO of Synthpop. "Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software. This funding helps us expand our coverage and deepen integrations so providers can scale their operations and expand access to care.” 

The round was led by Ansa Capital, with Marco DeMeireles, its cofounder and managing partner, joining Synthpop’s board of directors. Defy.vc and Peterson Ventures participated in the round, alongside Storm Ventures and strategic investor Bruce Broussard. 

The funding news comes shortly after the airt team – led by Davor Runje and Hajdi Cenan, who built FastStream and FastAgency, and made major contributions to AutoGen, Microsoft’s open-source framework for building agentic AI applications –  joined Synthpop to accelerate its AI workflow capabilities. Synthpop will use this round of funding to continue expanding the team, deepen their product capabilities and further expand into additional health care verticals. 

“Synthpop stood out to us for its ability to automate complex, real-world healthcare workflows with speed, accuracy, and compliance,” said Medha Agarwal, general partner at Defy.vc. “We’ve been impressed by their progress as investors, and we’re excited to double down. Their multi-agent platform delivers immediate, measurable value for providers, dramatically reducing time, cost, and friction across the patient journey. With strong customer adoption and a world-class technical team, we believe Synthpop is building critical infrastructure for a more efficient, human-centered healthcare system, and we’re excited to support a mission that ultimately helps speed up and improve access to care for patients.” 

• Related: AI’s ‘moment’ has arrived for HME providers